Impact of Tenofovir Disoproxil Fumarate on the
Fasting Lipid Profile of Chronic Hepatitis B Patients
| | | | | Reported by Jules Levin
APASL 2015
March 12-15, Istanbul, Turkey
Fehmi Tabak1, Henry L.Y. Chan2, Sang Hoon Ahn3, Seng Gee Lim4, Calvin Pan5, Ramazan Idilman6, Lanjia Lin7, Phillip Dinh7, Eduardo B. Martins7, Prista Charuworn7, Tak Yin Tsang8, Scott Fung9, Wan-Long Chuang10, Arun Sanyal11, Samuel Lee12, Mehta Rajiv13, Wendy Cheng14, Patrick Marcellin15
1University of Istanbul, Istanbul, Turkey; 2Prince of Wales Hospital, The Chinese University of Hong Kong; 3Yonsei University College of Medicine, Seoul, South Korea; 4Yong Loo Lin School of Medicine, National University of Singapore; 5NYU Langone Medical Center, NYU School of Medicine, New York, NY, USA; 6Ankara University School of Medicine, Department of Gastroenterology, Ankara, Turkey; 7Gilead Sciences, Inc., Foster City, CA, USA; 8Princess Margaret Hospital, Hong Kong; 9Toronto General Hospital, Toronto, ON, Canada; 10Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; 11Virginia Commonwealth University School of Medicine, Richmond, VA, USA; 12University of Calgary, Calgary, Alberta, Canada; 13Liver Clinic, Surat, India; 14Royal Perth Hospital, Perth, Australia; 15Hopital Beaujon, University of Paris, France
| | |
|  | |
|
|
